World’s First Human Implant of a 3D-Printed Cornea Restores Sight
December 15, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Background
Prurigo nodularis is a chronic and perplexing dermatological condition characterized by the development of intensely itchy, firm nodules or papules on the skin’s surface. This disorder may have a major detrimental effect on a person’s quality of life, leading to relentless scratching and pain. Prurigo nodularis remains a challenging and enigmatic disease that continues to baffle both patients and healthcare professionals.
This skin disorder presents a considerable burden for those affected, as it disrupts daily activities, impairs sleep, and causes considerable distress.
Epidemiology
Prevalence: Prurigo nodularis is considered a relatively rare skin disorder. Exact prevalence figures vary among different studies and populations; many individuals diagnosed with prurigo nodularis typically manifest symptoms between the ages of 51 & 65, although there have been documented instances of the condition occurring in individuals across various age groups. Although prurigo nodularis affects both sexes, it appears to exhibit a higher prevalence and greater severity among females.
Age and Gender: Prurigo nodularis can affect individuals of all ages, but it tends to be more common in adults and is rarely seen in children. The frequency of affected women is higher than that of affected men, suggesting a slight female predominance.
Geographic Variations: The prevalence of Prurigo nodularis may vary by geographical region. Some studies have suggested higher prevalence rates in certain tropical and subtropical regions, although the exact reasons for these variations are not well understood.
Impact on Quality of Life: Prurigo nodularis can have a major negative effect on an individual’s quality of life due to continual itching. Sleep disturbances, depression, and anxiety are expected consequences of the condition, and patients often report a reduced ability to engage in daily activities.
Anatomy
Pathophysiology
Chronic Itch Sensation: Prurigo nodularis is primarily driven by persistent and intense itching (pruritus). It is thought to be triggered by various factors, such as insect bites, allergies, skin irritants, or underlying skin disorders. The constant itch-scratch cycle can lead to the formation of nodules or papules.
Neurogenic Inflammation: Itch sensation is mediated by nerve fibers known as C-fibers and A-delta fibers in the skin. In PN, chronic itching can lead to increased activity of these nerve fibers. This, in turn, leads to neurogenic inflammation, with the release of neuropeptides like substance P and calcitonin gene-related peptide (CGRP), which cause vasodilation and local inflammation in the skin.
Skin Barrier Dysfunction: Prurigo nodularis is associated with impaired skin barrier function. This may result from repeated trauma to the skin due to scratching, which disrupts the normal skin structure and function. The compromised skin barrier allows allergens, irritants, and microbes to penetrate more easily, exacerbating inflammation.
Inflammatory Mediators: The chronic inflammation and immune response in prurigo nodularis involve various inflammatory mediators, such as histamines, cytokines (e.g., interleukin-1, interleukin-6), and chemokines. These mediators recruit immune cells to the site of skin lesions, leading to further inflammation and tissue damage.
Secondary Infections: Due to the frequent scratching and open sores in affected areas, secondary bacterial infections are not uncommon in prurigo nodularis. These infections can further worsen the skin condition and cause additional discomfort.
Psychological Factors: Stress, anxiety, and depression are often associated with prurigo nodularis. These emotional factors can exacerbate itching and the itch-scratch cycle, further complicating the disease’s pathophysiology.
Etiology
Chronic Itching (Pruritus): The most significant factor in the development of prurigo nodularis is chronic and persistent itching (pruritus). It often begins with an initial skin irritation or underlying skin condition, such as eczema, insect bites, or dermatitis.
Skin Trauma: Frequent and vigorous scratching, rubbing, or picking at the skin can cause trauma to the skin and lead to the development of nodules. This can create a vicious cycle of itching and scratching, worsening the condition.
Psychological Factors: Emotional stress, anxiety, and psychological factors can exacerbate the itching and may play a role in the development and persistence of prurigo nodularis. Some individuals with this condition may experience a heightened emotional response to their symptoms.
Underlying Skin Conditions: prurigo nodularis is often associated with other skin conditions contact dermatitis and eczema. The presence of these underlying skin conditions can contribute to the development of nodules.
Neurological Factors: Abnormalities in the nervous system, particularly nerve fibers that transmit itch signals, may be involved in prurigo nodularis. These abnormalities can lead to chronic itching and a heightened sensitivity to itch sensations.
Immune System Involvement: There is some evidence to suggest that the immune system may play a role in the development of prurigo nodularis, as specific immune cells and inflammatory processes may be activated in affected skin areas.
Genetics
Prognostic Factors
Psychological Factors: Psychological elements like anxiety & depression can have an influence on how prurigo nodularis develops. Managing stress and seeking mental health support can help improve the prognosis.
Coexisting Skin Conditions: The presence of other skin conditions, such as eczema & atopic dermatitis can complicate the management of prurigo nodularis. Treating these comorbid conditions can influence the overall prognosis.
Underlying Causes: Identifying and addressing any underlying causes or triggers of PN, such as allergic reactions or chronic inflammation, can help improve the prognosis.
Clinical History
Prurigo nodularis can affect individuals of various age groups. However, it is most observed in adults, typically in middle-aged or older individuals. The condition can develop at any age, but it tends to become more prevalent as people get older. It is less common in children and adolescents. The exact age group affected can vary, but the condition is generally more frequent in individuals over the age of 40.
Physical Examination
Inspection:
Assess the distribution and location of nodules or papules. Lesions of prurigo nodularis frequently develop on the extensor surfaces of the limbs, including the knees and elbows.
Analyse the nodules dimensions, form, and colour. They are usually reddish-brown to dark brown, solid, and dome-shaped.
Look for excoriations (scratch marks), erosions, and secondary infection in the affected areas.
Check for any signs of scarring or hyperpigmentation in areas where older nodules have healed.
Palpation:
Gently palpate the nodules to assess their consistency, tenderness, and warmth.
Note if the nodules feel firm and well-defined, and whether they are associated with pain or tenderness upon touch.
Skin folds and flexural areas:
Examine skin folds and flexural areas, as prurigo nodularis can sometimes affect these regions.
Note any evidence of lichenification (thickened, leathery skin) in these areas.
Regional lymph nodes:
Check nearby lymph nodes for enlargement, as prurigo nodularis may lead to localized lymphadenopathy if secondary infection is present.
Itch assessment:
Assess the severity of itching (pruritus) by asking the patient to rate it on a scale. Severe itching is a hallmark of prurigo nodularis.
Age group
Associated comorbidity
Atopic Dermatitis: Atopic dermatitis is a long-term inflammatory skin disease that produces itching, redness, and malfunction of the skin barrier. Prurigo nodularis can co-occur with this condition.
Chronic Itch: Persistent and severe itching is a characteristic of prurigo nodularis. Conditions or activities that lead to chronic itching, such as dry skin, insect bites, or allergies, can exacerbate the nodules.
Stress and Anxiety: Psychological factors, including stress and anxiety, can worsen itching and contribute to the development of nodules in some individuals.
Autoimmune Diseases: Prurigo nodularis may be associated with autoimmune disorders like celiac disease, thyroid disorders, or systemic lupus erythematosus.
Neurological Conditions: Conditions like neuropathy (nerve damage) and restless leg syndrome can lead to itching and may exacerbate Prurigo nodularis symptoms.
Infections: Skin infections, such as Staphylococcus aureus, can worsen the condition. Bacterial and fungal infections can lead to increased itching and inflammation.
Medications: Certain medications, especially those that affect the immune system, can be associated with Prurigo nodularis. For example, immune-suppressing drugs used in organ transplant patients.
Associated activity
Acuity of presentation
Gradual Onset: Prurigo nodularis typically presents with a gradual onset of symptoms. It may start as small, itchy bumps or nodules that slowly increase in size and number over time.
Itching: Pruritus, or itching, is the characteristic symptom of Prurigo nodularis. The itching can be intense and distressing, leading to repeated scratching, which in turn can exacerbate the condition.
Nodules or Papules: The primary characteristic of PN is the presence of raised, firm nodules or papules on the skin. These lesions may vary in size from a few millimeters to several centimeters in diameter.
Variable Distribution: Prurigo nodularis can affect any part of the body. Common locations include the arms, legs, neck, back, and extensor surfaces, but it can occur anywhere on the skin.
Excoriation: Due to the intense itching, patients often exhibit signs of excoriation (scratching or rubbing the skin), leading to secondary changes in the skin, such as open sores, scabs, and crusts.
Lichenification: Over time, chronic scratching and rubbing can lead to lichenification, a thickening and hardening of the skin. This further complicates the presentation.
Variable Severity: The severity of Prurigo nodularis can vary from person to person. Some individuals may have only a few nodules, while others may have widespread and severe involvement.
Psychological Impact: The constant itching and the appearance of the skin lesions can significantly impact a person’s quality of life. Two psychological symptoms that prurigo nodularis may induce are anxiety and depression.
Chronic Course: Prurigo nodularis tends to be a chronic condition with periodic flare-ups and remissions. It can persist for years or even decades.
Differential Diagnoses
Dermatofibroma: Dermatofibromas are benign skin tumors that can appear as firm, raised nodules. They may itch or become tender but are usually asymptomatic.
Contact Dermatitis: An inflammatory skin reaction known as contact dermatitis happens when the skin meets an irritant or allergen. It may result in redness, itchiness, and the growth of nodules or papules.
Actinic Keratosis: A common skin ailment called actinic keratosis is characterised by rough, scaly patches or lesions. Long-term sun or tanning exposure to ultraviolet (UV) radiation is the main cause of it. These patches can be pink, brown, or red in colour, and they’re frequently dry and scratchy.
Nodular Localized Cutaneous Amyloidosis: Nodular localized cutaneous amyloidosis is a subtype of amyloidosis that primarily affects the skin. In this condition, amyloid deposits form small, raised nodules or plaques on the skin. These lesions are often itchy and may appear brown or yellowish.
Atypical Fibroxanthoma: Atypical fibroxanthoma (AFX) is a rare, low-grade skin tumor that primarily occurs in the elderly, typically on sun-exposed areas of the skin. AFX is considered a type of cutaneous malignancy, but it is generally less aggressive compared to other skin cancers. It often appears as a solitary, firm, pink or red nodule.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Patient Education: Begin by educating the patient about Prurigo Nodularis, its chronic nature, and the importance of compliance with treatment regimens. Managing expectations is crucial.
Identify and Treat Underlying Causes: Prurigo nodularis can be associated with underlying conditions such as atopic dermatitis, chronic renal disease, or chronic infections. Identifying and addressing these underlying causes is essential.
Topical Treatments:
Topical Steroids: Low-potency or medium-potency topical steroids may be prescribed to reduce inflammation and itching.
Topical Calcineurin Inhibitors: These non-steroidal drugs, which include pimecrolimus and tacrolimus, can be applied to sensitive areas to assist lessen irritation and inflammation.
Topical Capsaicin: In some cases, topical capsaicin can be used to desensitize nerve endings and reduce itching.
Oral Medications:
Antihistamines: Oral antihistamines like cetirizine or loratadine may help relieve itching.
Gabapentin or Pregabalin: These medications are sometimes prescribed to manage neuropathic itching.
Tricyclic Antidepressants: Drugs like amitriptyline may be prescribed to help alleviate itching and improve sleep.
Phototherapy:
Narrowband UVB (NB-UVB) Phototherapy: In certain situations, moderate UVB light exposure can help lessen inflammation and itching.
Systemic Treatments:
Oral Corticosteroids: During illness flares, short doses of oral corticosteroids might be used to quickly reduce inflammation and itching.
Immunosuppressants: Medications like methotrexate, cyclosporine, or mycophenolate mofetil may be considered for severe cases of PN.
Biologic Therapies: Biologic drugs like dupilumab, which target specific immune system components, have shown promise in treating PN.
Psychological Support: Given the chronic nature of prurigo nodularis and its impact on mental health, psychological support, and counseling can be beneficial. Cognitive-behavioral therapy (CBT) and stress management techniques may be helpful.
Wound Care: Proper wound care and infection prevention are essential, as PN nodules can become open sores if scratched or damaged.
Lifestyle and Home Care: Encourage patients to avoid triggers, maintain proper skin hygiene, and use moisturizers to keep the skin well-hydrated.
Research Treatments: Since prurigo nodularis is a challenging condition, new treatments and clinical trials may offer hope for those who do not respond well to conventional therapies.
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
lifestyle-modifications-in-treating-prurigo-nodularis
Maintain Optimal Skin Hydration:
Regularly moisturize the skin with fragrance-free, hypoallergenic moisturizers to prevent dryness and itching.
Avoid Irritants:
Identify and eliminate potential irritants such as harsh soaps, fragranced products, and tight clothing that may aggravate itching.
Maintain a Comfortable Room Temperature:
Avoid extreme temperatures that can exacerbate itching. Keep the room temperature comfortable and use a humidifier in dry environments.
Stress Management:
Excessive stress can aggravate or start prurigo nodularis symptoms. Include stress-reduction strategies in your everyday practise, such as yoga, meditation, mindfulness, and relaxation exercises.
Itch-Relief Measures:
Keep cool packs in the refrigerator and apply them to itchy areas to provide temporary relief.
Trim fingernails to prevent skin damage from scratching.
Use over-the-counter or prescription anti-itch creams as recommended by a dermatologist.
Medications:
In extreme situations, your doctor might recommend oral or topical drugs to reduce inflammation and itching.
Dietary Considerations:
Some people report symptom improvement by avoiding certain trigger foods or following an anti-inflammatory diet. It may be worth exploring dietary modifications with the guidance of a healthcare professional.
Supportive Clothing:
Special clothing designed to reduce friction and pressure on affected areas can provide relief and prevent further skin damage.
Psychological Support:
PN can take a toll on mental health. Consider seeking support from a therapist or support group to help cope with the emotional aspects of living with this condition.
Regular Follow-ups:
Continuously consult with a dermatologist to monitor the condition, adjust treatment plans, and explore new therapies as they become available.
Role of Topical & Intralesional therapy in treating prurigo nodularis
triamcinolone acetonide
Concentrations of triamcinolone acetonide as low as 2.5 mg/mL have demonstrated effectiveness, but for pruriginous lesions that are more extensively scarred, higher concentrations may be necessary.
triamcinolone acetonide at concentrations ranging from 10 mg/mL-20 mg/mL into the affected area has demonstrated the ability to reduce the elevation of lesions and alleviate itching.
pimecrolimus 1%
pimecrolimus 1% demonstrates comparable efficacy to hydrocortisone and can be incorporated into a prolonged treatment plan.
menthol
In concentrations below 5%, menthol can help reduce itching by increasing the threshold for stimuli that trigger itching.
Effectiveness of novel therapies in treating prurigo nodularis
thalidomide is an immunomodulatory drug that functions as a central and peripheral depressant and has anti-inflammatory qualities due to its inhibition of tumour necrosis factor-α.
It has been applied to dermatological conditions that don’t respond to conventional treatment. It is believed that prurigo nodularis neurotoxic effects are that provide it with its therapeutic activity. 42 patients were treated with an average of 100 mg of thalidomide for 105 weeks in the largest study to date on the use of thalidomide in refractory prurigo nodularis.
Compared to thalidomide, lenalidomide has a 2000-fold higher potency.
Patients who have prurigo nodularis and are resistant to thalidomide and other treatments may benefit from lenalidomide as a stand-alone treatment.
lenalidomide has the advantage of reducing the frequency of peripheral neuropathy. It can also reduce the risk of thromboembolic events when taken with aspirin.
Effectiveness of Antihistamines & leukotriene inhibitors in treating prurigo nodularis
Antihistamines play a crucial role in the treatment of prurigo nodularis by targeting the elevated mast cell count within prurigo nodularis lesions.
A case series has demonstrated positive outcomes in individuals with chronic pruritus when employing a high-dose, non-sedating antihistamine during the day and transitioning to a sedating antihistamine at night.
fexofenadine & montelukast
The concurrent treatment with fexofenadine and montelukast demonstrated significant enhancements in skin lesions and alleviated itching in 11 out of 15 individuals suffering from both prurigo nodularis and pemphigoid nodularis. Remarkably, one patient achieved complete remission because of this treatment regimen.
Use of oral immunosuppressants in treating prurigo nodularis
cyclosporine
Patients with severe, refractory prurigo nodularis may benefit from the consideration of oral immunosuppressive treatment.
A retrospective study conducted at a single institution observed notable clinical enhancements, including a reduction in skin lesions and decreased itching, with the use of cyclosporine. On average, these improvements were observed within three weeks, with an average dosage of 3.1 mg/kg. This investigation, which involved eight patients, revealed that six of them achieved complete remission, and there were no recurrences observed after discontinuation of the treatment.
tacrolimus oral
Oral administration of tacrolimus exhibited a remarkable decrease in pruritus for a patient previously managed with cyclosporine to address prurigo nodularis condition.
role-of-cryotherapy-in-treating-prurigo-nodularis
Cryotherapy: Cryotherapy involves freezing the prurigo nodules using liquid nitrogen. This is a common approach for smaller, localized nodules. Cryotherapy can destroy the affected tissue and provide relief from itching.
Pulsed-dye laser treatment has the potential to decrease the blood vessel prominence in specific skin lesions.
management-of-prurigo-nodularis
Diagnosis and Assessment:
Proper diagnosis of prurigo nodularis is essential, often involving a clinical examination by a dermatologist or a healthcare provider with expertise in dermatology.
Detailed medical history and examination of skin lesions to confirm the diagnosis.
Assessment of the severity of symptoms, impact on the patient’s daily life, and any underlying medical conditions.
Education and Counseling:
Patient education is crucial to help individuals understand the nature of prurigo Nodularis and the chronicity of the condition.
Counseling regarding the importance of avoiding scratching and the potential for secondary infections.
Discussing treatment options and setting realistic expectations for improvement.
Topical Treatments:
Emollients and moisturizers to keep the skin hydrated and minimize dryness, which can exacerbate itching.
Topical corticosteroids to reduce inflammation and itching.
Topical calcineurin inhibitors (e.g., tacrolimus or pimecrolimus) to reduce inflammation and itching, especially in sensitive areas.
Topical anesthetics or cooling agents to provide temporary relief from itching.
Systemic Medications:
In more severe cases or when topical treatments are ineffective, systemic medications may be prescribed.
Antihistamines to help control itching and improve sleep quality.
Immunosuppressants like cyclosporine or methotrexate to reduce inflammation and itching.
Gabapentin or pregabalin for neuropathic itching in some cases.
If secondary bacterial infections are present, antibiotics may be prescribed.
Behavioral and Psychological Interventions:
Patients can manage the impulse to itch and treat any psychological issues contributing to the illness by using cognitive-behavioral therapy or other counselling procedures.
Stress management techniques, as stress can exacerbate itching.
Habit-reversal training to help patients become more aware of their scratching behavior and develop strategies to reduce it.
Phototherapy:
Narrowband UVB phototherapy can be effective in some cases, particularly for reducing itching and inflammation.
PUVA (psoralen plus UVA) therapy may also be considered in certain situations.
Support and Follow-up:
Regular follow-up appointments to monitor the progress of treatment and adjust the management plan as needed.
Encouragement and support for the patient to adhere to the prescribed treatment regimen.
Addressing any adverse effects or complications associated with the treatments.
Lifestyle Modifications:
Encouraging patients to avoid triggers that worsen itching, such as tight clothing, heat, and certain fabrics.
Promoting a healthy, well-balanced diet and adequate hydration to support skin health.
Research and Emerging Therapies:
Patients may be informed about ongoing research and clinical trials for potential new treatments or therapies.
Medication
Future Trends
Prurigo nodularis is a chronic and perplexing dermatological condition characterized by the development of intensely itchy, firm nodules or papules on the skin’s surface. This disorder may have a major detrimental effect on a person’s quality of life, leading to relentless scratching and pain. Prurigo nodularis remains a challenging and enigmatic disease that continues to baffle both patients and healthcare professionals.
This skin disorder presents a considerable burden for those affected, as it disrupts daily activities, impairs sleep, and causes considerable distress.
Prevalence: Prurigo nodularis is considered a relatively rare skin disorder. Exact prevalence figures vary among different studies and populations; many individuals diagnosed with prurigo nodularis typically manifest symptoms between the ages of 51 & 65, although there have been documented instances of the condition occurring in individuals across various age groups. Although prurigo nodularis affects both sexes, it appears to exhibit a higher prevalence and greater severity among females.
Age and Gender: Prurigo nodularis can affect individuals of all ages, but it tends to be more common in adults and is rarely seen in children. The frequency of affected women is higher than that of affected men, suggesting a slight female predominance.
Geographic Variations: The prevalence of Prurigo nodularis may vary by geographical region. Some studies have suggested higher prevalence rates in certain tropical and subtropical regions, although the exact reasons for these variations are not well understood.
Impact on Quality of Life: Prurigo nodularis can have a major negative effect on an individual’s quality of life due to continual itching. Sleep disturbances, depression, and anxiety are expected consequences of the condition, and patients often report a reduced ability to engage in daily activities.
Chronic Itch Sensation: Prurigo nodularis is primarily driven by persistent and intense itching (pruritus). It is thought to be triggered by various factors, such as insect bites, allergies, skin irritants, or underlying skin disorders. The constant itch-scratch cycle can lead to the formation of nodules or papules.
Neurogenic Inflammation: Itch sensation is mediated by nerve fibers known as C-fibers and A-delta fibers in the skin. In PN, chronic itching can lead to increased activity of these nerve fibers. This, in turn, leads to neurogenic inflammation, with the release of neuropeptides like substance P and calcitonin gene-related peptide (CGRP), which cause vasodilation and local inflammation in the skin.
Skin Barrier Dysfunction: Prurigo nodularis is associated with impaired skin barrier function. This may result from repeated trauma to the skin due to scratching, which disrupts the normal skin structure and function. The compromised skin barrier allows allergens, irritants, and microbes to penetrate more easily, exacerbating inflammation.
Inflammatory Mediators: The chronic inflammation and immune response in prurigo nodularis involve various inflammatory mediators, such as histamines, cytokines (e.g., interleukin-1, interleukin-6), and chemokines. These mediators recruit immune cells to the site of skin lesions, leading to further inflammation and tissue damage.
Secondary Infections: Due to the frequent scratching and open sores in affected areas, secondary bacterial infections are not uncommon in prurigo nodularis. These infections can further worsen the skin condition and cause additional discomfort.
Psychological Factors: Stress, anxiety, and depression are often associated with prurigo nodularis. These emotional factors can exacerbate itching and the itch-scratch cycle, further complicating the disease’s pathophysiology.
Chronic Itching (Pruritus): The most significant factor in the development of prurigo nodularis is chronic and persistent itching (pruritus). It often begins with an initial skin irritation or underlying skin condition, such as eczema, insect bites, or dermatitis.
Skin Trauma: Frequent and vigorous scratching, rubbing, or picking at the skin can cause trauma to the skin and lead to the development of nodules. This can create a vicious cycle of itching and scratching, worsening the condition.
Psychological Factors: Emotional stress, anxiety, and psychological factors can exacerbate the itching and may play a role in the development and persistence of prurigo nodularis. Some individuals with this condition may experience a heightened emotional response to their symptoms.
Underlying Skin Conditions: prurigo nodularis is often associated with other skin conditions contact dermatitis and eczema. The presence of these underlying skin conditions can contribute to the development of nodules.
Neurological Factors: Abnormalities in the nervous system, particularly nerve fibers that transmit itch signals, may be involved in prurigo nodularis. These abnormalities can lead to chronic itching and a heightened sensitivity to itch sensations.
Immune System Involvement: There is some evidence to suggest that the immune system may play a role in the development of prurigo nodularis, as specific immune cells and inflammatory processes may be activated in affected skin areas.
Psychological Factors: Psychological elements like anxiety & depression can have an influence on how prurigo nodularis develops. Managing stress and seeking mental health support can help improve the prognosis.
Coexisting Skin Conditions: The presence of other skin conditions, such as eczema & atopic dermatitis can complicate the management of prurigo nodularis. Treating these comorbid conditions can influence the overall prognosis.
Underlying Causes: Identifying and addressing any underlying causes or triggers of PN, such as allergic reactions or chronic inflammation, can help improve the prognosis.
Prurigo nodularis can affect individuals of various age groups. However, it is most observed in adults, typically in middle-aged or older individuals. The condition can develop at any age, but it tends to become more prevalent as people get older. It is less common in children and adolescents. The exact age group affected can vary, but the condition is generally more frequent in individuals over the age of 40.
Inspection:
Assess the distribution and location of nodules or papules. Lesions of prurigo nodularis frequently develop on the extensor surfaces of the limbs, including the knees and elbows.
Analyse the nodules dimensions, form, and colour. They are usually reddish-brown to dark brown, solid, and dome-shaped.
Look for excoriations (scratch marks), erosions, and secondary infection in the affected areas.
Check for any signs of scarring or hyperpigmentation in areas where older nodules have healed.
Palpation:
Gently palpate the nodules to assess their consistency, tenderness, and warmth.
Note if the nodules feel firm and well-defined, and whether they are associated with pain or tenderness upon touch.
Skin folds and flexural areas:
Examine skin folds and flexural areas, as prurigo nodularis can sometimes affect these regions.
Note any evidence of lichenification (thickened, leathery skin) in these areas.
Regional lymph nodes:
Check nearby lymph nodes for enlargement, as prurigo nodularis may lead to localized lymphadenopathy if secondary infection is present.
Itch assessment:
Assess the severity of itching (pruritus) by asking the patient to rate it on a scale. Severe itching is a hallmark of prurigo nodularis.
Atopic Dermatitis: Atopic dermatitis is a long-term inflammatory skin disease that produces itching, redness, and malfunction of the skin barrier. Prurigo nodularis can co-occur with this condition.
Chronic Itch: Persistent and severe itching is a characteristic of prurigo nodularis. Conditions or activities that lead to chronic itching, such as dry skin, insect bites, or allergies, can exacerbate the nodules.
Stress and Anxiety: Psychological factors, including stress and anxiety, can worsen itching and contribute to the development of nodules in some individuals.
Autoimmune Diseases: Prurigo nodularis may be associated with autoimmune disorders like celiac disease, thyroid disorders, or systemic lupus erythematosus.
Neurological Conditions: Conditions like neuropathy (nerve damage) and restless leg syndrome can lead to itching and may exacerbate Prurigo nodularis symptoms.
Infections: Skin infections, such as Staphylococcus aureus, can worsen the condition. Bacterial and fungal infections can lead to increased itching and inflammation.
Medications: Certain medications, especially those that affect the immune system, can be associated with Prurigo nodularis. For example, immune-suppressing drugs used in organ transplant patients.
Gradual Onset: Prurigo nodularis typically presents with a gradual onset of symptoms. It may start as small, itchy bumps or nodules that slowly increase in size and number over time.
Itching: Pruritus, or itching, is the characteristic symptom of Prurigo nodularis. The itching can be intense and distressing, leading to repeated scratching, which in turn can exacerbate the condition.
Nodules or Papules: The primary characteristic of PN is the presence of raised, firm nodules or papules on the skin. These lesions may vary in size from a few millimeters to several centimeters in diameter.
Variable Distribution: Prurigo nodularis can affect any part of the body. Common locations include the arms, legs, neck, back, and extensor surfaces, but it can occur anywhere on the skin.
Excoriation: Due to the intense itching, patients often exhibit signs of excoriation (scratching or rubbing the skin), leading to secondary changes in the skin, such as open sores, scabs, and crusts.
Lichenification: Over time, chronic scratching and rubbing can lead to lichenification, a thickening and hardening of the skin. This further complicates the presentation.
Variable Severity: The severity of Prurigo nodularis can vary from person to person. Some individuals may have only a few nodules, while others may have widespread and severe involvement.
Psychological Impact: The constant itching and the appearance of the skin lesions can significantly impact a person’s quality of life. Two psychological symptoms that prurigo nodularis may induce are anxiety and depression.
Chronic Course: Prurigo nodularis tends to be a chronic condition with periodic flare-ups and remissions. It can persist for years or even decades.
Dermatofibroma: Dermatofibromas are benign skin tumors that can appear as firm, raised nodules. They may itch or become tender but are usually asymptomatic.
Contact Dermatitis: An inflammatory skin reaction known as contact dermatitis happens when the skin meets an irritant or allergen. It may result in redness, itchiness, and the growth of nodules or papules.
Actinic Keratosis: A common skin ailment called actinic keratosis is characterised by rough, scaly patches or lesions. Long-term sun or tanning exposure to ultraviolet (UV) radiation is the main cause of it. These patches can be pink, brown, or red in colour, and they’re frequently dry and scratchy.
Nodular Localized Cutaneous Amyloidosis: Nodular localized cutaneous amyloidosis is a subtype of amyloidosis that primarily affects the skin. In this condition, amyloid deposits form small, raised nodules or plaques on the skin. These lesions are often itchy and may appear brown or yellowish.
Atypical Fibroxanthoma: Atypical fibroxanthoma (AFX) is a rare, low-grade skin tumor that primarily occurs in the elderly, typically on sun-exposed areas of the skin. AFX is considered a type of cutaneous malignancy, but it is generally less aggressive compared to other skin cancers. It often appears as a solitary, firm, pink or red nodule.
Patient Education: Begin by educating the patient about Prurigo Nodularis, its chronic nature, and the importance of compliance with treatment regimens. Managing expectations is crucial.
Identify and Treat Underlying Causes: Prurigo nodularis can be associated with underlying conditions such as atopic dermatitis, chronic renal disease, or chronic infections. Identifying and addressing these underlying causes is essential.
Topical Treatments:
Topical Steroids: Low-potency or medium-potency topical steroids may be prescribed to reduce inflammation and itching.
Topical Calcineurin Inhibitors: These non-steroidal drugs, which include pimecrolimus and tacrolimus, can be applied to sensitive areas to assist lessen irritation and inflammation.
Topical Capsaicin: In some cases, topical capsaicin can be used to desensitize nerve endings and reduce itching.
Oral Medications:
Antihistamines: Oral antihistamines like cetirizine or loratadine may help relieve itching.
Gabapentin or Pregabalin: These medications are sometimes prescribed to manage neuropathic itching.
Tricyclic Antidepressants: Drugs like amitriptyline may be prescribed to help alleviate itching and improve sleep.
Phototherapy:
Narrowband UVB (NB-UVB) Phototherapy: In certain situations, moderate UVB light exposure can help lessen inflammation and itching.
Systemic Treatments:
Oral Corticosteroids: During illness flares, short doses of oral corticosteroids might be used to quickly reduce inflammation and itching.
Immunosuppressants: Medications like methotrexate, cyclosporine, or mycophenolate mofetil may be considered for severe cases of PN.
Biologic Therapies: Biologic drugs like dupilumab, which target specific immune system components, have shown promise in treating PN.
Psychological Support: Given the chronic nature of prurigo nodularis and its impact on mental health, psychological support, and counseling can be beneficial. Cognitive-behavioral therapy (CBT) and stress management techniques may be helpful.
Wound Care: Proper wound care and infection prevention are essential, as PN nodules can become open sores if scratched or damaged.
Lifestyle and Home Care: Encourage patients to avoid triggers, maintain proper skin hygiene, and use moisturizers to keep the skin well-hydrated.
Research Treatments: Since prurigo nodularis is a challenging condition, new treatments and clinical trials may offer hope for those who do not respond well to conventional therapies.
Maintain Optimal Skin Hydration:
Regularly moisturize the skin with fragrance-free, hypoallergenic moisturizers to prevent dryness and itching.
Avoid Irritants:
Identify and eliminate potential irritants such as harsh soaps, fragranced products, and tight clothing that may aggravate itching.
Maintain a Comfortable Room Temperature:
Avoid extreme temperatures that can exacerbate itching. Keep the room temperature comfortable and use a humidifier in dry environments.
Stress Management:
Excessive stress can aggravate or start prurigo nodularis symptoms. Include stress-reduction strategies in your everyday practise, such as yoga, meditation, mindfulness, and relaxation exercises.
Itch-Relief Measures:
Keep cool packs in the refrigerator and apply them to itchy areas to provide temporary relief.
Trim fingernails to prevent skin damage from scratching.
Use over-the-counter or prescription anti-itch creams as recommended by a dermatologist.
Medications:
In extreme situations, your doctor might recommend oral or topical drugs to reduce inflammation and itching.
Dietary Considerations:
Some people report symptom improvement by avoiding certain trigger foods or following an anti-inflammatory diet. It may be worth exploring dietary modifications with the guidance of a healthcare professional.
Supportive Clothing:
Special clothing designed to reduce friction and pressure on affected areas can provide relief and prevent further skin damage.
Psychological Support:
PN can take a toll on mental health. Consider seeking support from a therapist or support group to help cope with the emotional aspects of living with this condition.
Regular Follow-ups:
Continuously consult with a dermatologist to monitor the condition, adjust treatment plans, and explore new therapies as they become available.
triamcinolone acetonide
Concentrations of triamcinolone acetonide as low as 2.5 mg/mL have demonstrated effectiveness, but for pruriginous lesions that are more extensively scarred, higher concentrations may be necessary.
triamcinolone acetonide at concentrations ranging from 10 mg/mL-20 mg/mL into the affected area has demonstrated the ability to reduce the elevation of lesions and alleviate itching.
pimecrolimus 1%
pimecrolimus 1% demonstrates comparable efficacy to hydrocortisone and can be incorporated into a prolonged treatment plan.
menthol
In concentrations below 5%, menthol can help reduce itching by increasing the threshold for stimuli that trigger itching.
thalidomide is an immunomodulatory drug that functions as a central and peripheral depressant and has anti-inflammatory qualities due to its inhibition of tumour necrosis factor-α.
It has been applied to dermatological conditions that don’t respond to conventional treatment. It is believed that prurigo nodularis neurotoxic effects are that provide it with its therapeutic activity. 42 patients were treated with an average of 100 mg of thalidomide for 105 weeks in the largest study to date on the use of thalidomide in refractory prurigo nodularis.
Compared to thalidomide, lenalidomide has a 2000-fold higher potency.
Patients who have prurigo nodularis and are resistant to thalidomide and other treatments may benefit from lenalidomide as a stand-alone treatment.
lenalidomide has the advantage of reducing the frequency of peripheral neuropathy. It can also reduce the risk of thromboembolic events when taken with aspirin.
Antihistamines play a crucial role in the treatment of prurigo nodularis by targeting the elevated mast cell count within prurigo nodularis lesions.
A case series has demonstrated positive outcomes in individuals with chronic pruritus when employing a high-dose, non-sedating antihistamine during the day and transitioning to a sedating antihistamine at night.
fexofenadine & montelukast
The concurrent treatment with fexofenadine and montelukast demonstrated significant enhancements in skin lesions and alleviated itching in 11 out of 15 individuals suffering from both prurigo nodularis and pemphigoid nodularis. Remarkably, one patient achieved complete remission because of this treatment regimen.
cyclosporine
Patients with severe, refractory prurigo nodularis may benefit from the consideration of oral immunosuppressive treatment.
A retrospective study conducted at a single institution observed notable clinical enhancements, including a reduction in skin lesions and decreased itching, with the use of cyclosporine. On average, these improvements were observed within three weeks, with an average dosage of 3.1 mg/kg. This investigation, which involved eight patients, revealed that six of them achieved complete remission, and there were no recurrences observed after discontinuation of the treatment.
tacrolimus oral
Oral administration of tacrolimus exhibited a remarkable decrease in pruritus for a patient previously managed with cyclosporine to address prurigo nodularis condition.
Cryotherapy: Cryotherapy involves freezing the prurigo nodules using liquid nitrogen. This is a common approach for smaller, localized nodules. Cryotherapy can destroy the affected tissue and provide relief from itching.
Pulsed-dye laser treatment has the potential to decrease the blood vessel prominence in specific skin lesions.
Diagnosis and Assessment:
Proper diagnosis of prurigo nodularis is essential, often involving a clinical examination by a dermatologist or a healthcare provider with expertise in dermatology.
Detailed medical history and examination of skin lesions to confirm the diagnosis.
Assessment of the severity of symptoms, impact on the patient’s daily life, and any underlying medical conditions.
Education and Counseling:
Patient education is crucial to help individuals understand the nature of prurigo Nodularis and the chronicity of the condition.
Counseling regarding the importance of avoiding scratching and the potential for secondary infections.
Discussing treatment options and setting realistic expectations for improvement.
Topical Treatments:
Emollients and moisturizers to keep the skin hydrated and minimize dryness, which can exacerbate itching.
Topical corticosteroids to reduce inflammation and itching.
Topical calcineurin inhibitors (e.g., tacrolimus or pimecrolimus) to reduce inflammation and itching, especially in sensitive areas.
Topical anesthetics or cooling agents to provide temporary relief from itching.
Systemic Medications:
In more severe cases or when topical treatments are ineffective, systemic medications may be prescribed.
Antihistamines to help control itching and improve sleep quality.
Immunosuppressants like cyclosporine or methotrexate to reduce inflammation and itching.
Gabapentin or pregabalin for neuropathic itching in some cases.
If secondary bacterial infections are present, antibiotics may be prescribed.
Behavioral and Psychological Interventions:
Patients can manage the impulse to itch and treat any psychological issues contributing to the illness by using cognitive-behavioral therapy or other counselling procedures.
Stress management techniques, as stress can exacerbate itching.
Habit-reversal training to help patients become more aware of their scratching behavior and develop strategies to reduce it.
Phototherapy:
Narrowband UVB phototherapy can be effective in some cases, particularly for reducing itching and inflammation.
PUVA (psoralen plus UVA) therapy may also be considered in certain situations.
Support and Follow-up:
Regular follow-up appointments to monitor the progress of treatment and adjust the management plan as needed.
Encouragement and support for the patient to adhere to the prescribed treatment regimen.
Addressing any adverse effects or complications associated with the treatments.
Lifestyle Modifications:
Encouraging patients to avoid triggers that worsen itching, such as tight clothing, heat, and certain fabrics.
Promoting a healthy, well-balanced diet and adequate hydration to support skin health.
Research and Emerging Therapies:
Patients may be informed about ongoing research and clinical trials for potential new treatments or therapies.
Prurigo nodularis is a chronic and perplexing dermatological condition characterized by the development of intensely itchy, firm nodules or papules on the skin’s surface. This disorder may have a major detrimental effect on a person’s quality of life, leading to relentless scratching and pain. Prurigo nodularis remains a challenging and enigmatic disease that continues to baffle both patients and healthcare professionals.
This skin disorder presents a considerable burden for those affected, as it disrupts daily activities, impairs sleep, and causes considerable distress.
Prevalence: Prurigo nodularis is considered a relatively rare skin disorder. Exact prevalence figures vary among different studies and populations; many individuals diagnosed with prurigo nodularis typically manifest symptoms between the ages of 51 & 65, although there have been documented instances of the condition occurring in individuals across various age groups. Although prurigo nodularis affects both sexes, it appears to exhibit a higher prevalence and greater severity among females.
Age and Gender: Prurigo nodularis can affect individuals of all ages, but it tends to be more common in adults and is rarely seen in children. The frequency of affected women is higher than that of affected men, suggesting a slight female predominance.
Geographic Variations: The prevalence of Prurigo nodularis may vary by geographical region. Some studies have suggested higher prevalence rates in certain tropical and subtropical regions, although the exact reasons for these variations are not well understood.
Impact on Quality of Life: Prurigo nodularis can have a major negative effect on an individual’s quality of life due to continual itching. Sleep disturbances, depression, and anxiety are expected consequences of the condition, and patients often report a reduced ability to engage in daily activities.
Chronic Itch Sensation: Prurigo nodularis is primarily driven by persistent and intense itching (pruritus). It is thought to be triggered by various factors, such as insect bites, allergies, skin irritants, or underlying skin disorders. The constant itch-scratch cycle can lead to the formation of nodules or papules.
Neurogenic Inflammation: Itch sensation is mediated by nerve fibers known as C-fibers and A-delta fibers in the skin. In PN, chronic itching can lead to increased activity of these nerve fibers. This, in turn, leads to neurogenic inflammation, with the release of neuropeptides like substance P and calcitonin gene-related peptide (CGRP), which cause vasodilation and local inflammation in the skin.
Skin Barrier Dysfunction: Prurigo nodularis is associated with impaired skin barrier function. This may result from repeated trauma to the skin due to scratching, which disrupts the normal skin structure and function. The compromised skin barrier allows allergens, irritants, and microbes to penetrate more easily, exacerbating inflammation.
Inflammatory Mediators: The chronic inflammation and immune response in prurigo nodularis involve various inflammatory mediators, such as histamines, cytokines (e.g., interleukin-1, interleukin-6), and chemokines. These mediators recruit immune cells to the site of skin lesions, leading to further inflammation and tissue damage.
Secondary Infections: Due to the frequent scratching and open sores in affected areas, secondary bacterial infections are not uncommon in prurigo nodularis. These infections can further worsen the skin condition and cause additional discomfort.
Psychological Factors: Stress, anxiety, and depression are often associated with prurigo nodularis. These emotional factors can exacerbate itching and the itch-scratch cycle, further complicating the disease’s pathophysiology.
Chronic Itching (Pruritus): The most significant factor in the development of prurigo nodularis is chronic and persistent itching (pruritus). It often begins with an initial skin irritation or underlying skin condition, such as eczema, insect bites, or dermatitis.
Skin Trauma: Frequent and vigorous scratching, rubbing, or picking at the skin can cause trauma to the skin and lead to the development of nodules. This can create a vicious cycle of itching and scratching, worsening the condition.
Psychological Factors: Emotional stress, anxiety, and psychological factors can exacerbate the itching and may play a role in the development and persistence of prurigo nodularis. Some individuals with this condition may experience a heightened emotional response to their symptoms.
Underlying Skin Conditions: prurigo nodularis is often associated with other skin conditions contact dermatitis and eczema. The presence of these underlying skin conditions can contribute to the development of nodules.
Neurological Factors: Abnormalities in the nervous system, particularly nerve fibers that transmit itch signals, may be involved in prurigo nodularis. These abnormalities can lead to chronic itching and a heightened sensitivity to itch sensations.
Immune System Involvement: There is some evidence to suggest that the immune system may play a role in the development of prurigo nodularis, as specific immune cells and inflammatory processes may be activated in affected skin areas.
Psychological Factors: Psychological elements like anxiety & depression can have an influence on how prurigo nodularis develops. Managing stress and seeking mental health support can help improve the prognosis.
Coexisting Skin Conditions: The presence of other skin conditions, such as eczema & atopic dermatitis can complicate the management of prurigo nodularis. Treating these comorbid conditions can influence the overall prognosis.
Underlying Causes: Identifying and addressing any underlying causes or triggers of PN, such as allergic reactions or chronic inflammation, can help improve the prognosis.
Prurigo nodularis can affect individuals of various age groups. However, it is most observed in adults, typically in middle-aged or older individuals. The condition can develop at any age, but it tends to become more prevalent as people get older. It is less common in children and adolescents. The exact age group affected can vary, but the condition is generally more frequent in individuals over the age of 40.
Inspection:
Assess the distribution and location of nodules or papules. Lesions of prurigo nodularis frequently develop on the extensor surfaces of the limbs, including the knees and elbows.
Analyse the nodules dimensions, form, and colour. They are usually reddish-brown to dark brown, solid, and dome-shaped.
Look for excoriations (scratch marks), erosions, and secondary infection in the affected areas.
Check for any signs of scarring or hyperpigmentation in areas where older nodules have healed.
Palpation:
Gently palpate the nodules to assess their consistency, tenderness, and warmth.
Note if the nodules feel firm and well-defined, and whether they are associated with pain or tenderness upon touch.
Skin folds and flexural areas:
Examine skin folds and flexural areas, as prurigo nodularis can sometimes affect these regions.
Note any evidence of lichenification (thickened, leathery skin) in these areas.
Regional lymph nodes:
Check nearby lymph nodes for enlargement, as prurigo nodularis may lead to localized lymphadenopathy if secondary infection is present.
Itch assessment:
Assess the severity of itching (pruritus) by asking the patient to rate it on a scale. Severe itching is a hallmark of prurigo nodularis.
Atopic Dermatitis: Atopic dermatitis is a long-term inflammatory skin disease that produces itching, redness, and malfunction of the skin barrier. Prurigo nodularis can co-occur with this condition.
Chronic Itch: Persistent and severe itching is a characteristic of prurigo nodularis. Conditions or activities that lead to chronic itching, such as dry skin, insect bites, or allergies, can exacerbate the nodules.
Stress and Anxiety: Psychological factors, including stress and anxiety, can worsen itching and contribute to the development of nodules in some individuals.
Autoimmune Diseases: Prurigo nodularis may be associated with autoimmune disorders like celiac disease, thyroid disorders, or systemic lupus erythematosus.
Neurological Conditions: Conditions like neuropathy (nerve damage) and restless leg syndrome can lead to itching and may exacerbate Prurigo nodularis symptoms.
Infections: Skin infections, such as Staphylococcus aureus, can worsen the condition. Bacterial and fungal infections can lead to increased itching and inflammation.
Medications: Certain medications, especially those that affect the immune system, can be associated with Prurigo nodularis. For example, immune-suppressing drugs used in organ transplant patients.
Gradual Onset: Prurigo nodularis typically presents with a gradual onset of symptoms. It may start as small, itchy bumps or nodules that slowly increase in size and number over time.
Itching: Pruritus, or itching, is the characteristic symptom of Prurigo nodularis. The itching can be intense and distressing, leading to repeated scratching, which in turn can exacerbate the condition.
Nodules or Papules: The primary characteristic of PN is the presence of raised, firm nodules or papules on the skin. These lesions may vary in size from a few millimeters to several centimeters in diameter.
Variable Distribution: Prurigo nodularis can affect any part of the body. Common locations include the arms, legs, neck, back, and extensor surfaces, but it can occur anywhere on the skin.
Excoriation: Due to the intense itching, patients often exhibit signs of excoriation (scratching or rubbing the skin), leading to secondary changes in the skin, such as open sores, scabs, and crusts.
Lichenification: Over time, chronic scratching and rubbing can lead to lichenification, a thickening and hardening of the skin. This further complicates the presentation.
Variable Severity: The severity of Prurigo nodularis can vary from person to person. Some individuals may have only a few nodules, while others may have widespread and severe involvement.
Psychological Impact: The constant itching and the appearance of the skin lesions can significantly impact a person’s quality of life. Two psychological symptoms that prurigo nodularis may induce are anxiety and depression.
Chronic Course: Prurigo nodularis tends to be a chronic condition with periodic flare-ups and remissions. It can persist for years or even decades.
Dermatofibroma: Dermatofibromas are benign skin tumors that can appear as firm, raised nodules. They may itch or become tender but are usually asymptomatic.
Contact Dermatitis: An inflammatory skin reaction known as contact dermatitis happens when the skin meets an irritant or allergen. It may result in redness, itchiness, and the growth of nodules or papules.
Actinic Keratosis: A common skin ailment called actinic keratosis is characterised by rough, scaly patches or lesions. Long-term sun or tanning exposure to ultraviolet (UV) radiation is the main cause of it. These patches can be pink, brown, or red in colour, and they’re frequently dry and scratchy.
Nodular Localized Cutaneous Amyloidosis: Nodular localized cutaneous amyloidosis is a subtype of amyloidosis that primarily affects the skin. In this condition, amyloid deposits form small, raised nodules or plaques on the skin. These lesions are often itchy and may appear brown or yellowish.
Atypical Fibroxanthoma: Atypical fibroxanthoma (AFX) is a rare, low-grade skin tumor that primarily occurs in the elderly, typically on sun-exposed areas of the skin. AFX is considered a type of cutaneous malignancy, but it is generally less aggressive compared to other skin cancers. It often appears as a solitary, firm, pink or red nodule.
Patient Education: Begin by educating the patient about Prurigo Nodularis, its chronic nature, and the importance of compliance with treatment regimens. Managing expectations is crucial.
Identify and Treat Underlying Causes: Prurigo nodularis can be associated with underlying conditions such as atopic dermatitis, chronic renal disease, or chronic infections. Identifying and addressing these underlying causes is essential.
Topical Treatments:
Topical Steroids: Low-potency or medium-potency topical steroids may be prescribed to reduce inflammation and itching.
Topical Calcineurin Inhibitors: These non-steroidal drugs, which include pimecrolimus and tacrolimus, can be applied to sensitive areas to assist lessen irritation and inflammation.
Topical Capsaicin: In some cases, topical capsaicin can be used to desensitize nerve endings and reduce itching.
Oral Medications:
Antihistamines: Oral antihistamines like cetirizine or loratadine may help relieve itching.
Gabapentin or Pregabalin: These medications are sometimes prescribed to manage neuropathic itching.
Tricyclic Antidepressants: Drugs like amitriptyline may be prescribed to help alleviate itching and improve sleep.
Phototherapy:
Narrowband UVB (NB-UVB) Phototherapy: In certain situations, moderate UVB light exposure can help lessen inflammation and itching.
Systemic Treatments:
Oral Corticosteroids: During illness flares, short doses of oral corticosteroids might be used to quickly reduce inflammation and itching.
Immunosuppressants: Medications like methotrexate, cyclosporine, or mycophenolate mofetil may be considered for severe cases of PN.
Biologic Therapies: Biologic drugs like dupilumab, which target specific immune system components, have shown promise in treating PN.
Psychological Support: Given the chronic nature of prurigo nodularis and its impact on mental health, psychological support, and counseling can be beneficial. Cognitive-behavioral therapy (CBT) and stress management techniques may be helpful.
Wound Care: Proper wound care and infection prevention are essential, as PN nodules can become open sores if scratched or damaged.
Lifestyle and Home Care: Encourage patients to avoid triggers, maintain proper skin hygiene, and use moisturizers to keep the skin well-hydrated.
Research Treatments: Since prurigo nodularis is a challenging condition, new treatments and clinical trials may offer hope for those who do not respond well to conventional therapies.
Maintain Optimal Skin Hydration:
Regularly moisturize the skin with fragrance-free, hypoallergenic moisturizers to prevent dryness and itching.
Avoid Irritants:
Identify and eliminate potential irritants such as harsh soaps, fragranced products, and tight clothing that may aggravate itching.
Maintain a Comfortable Room Temperature:
Avoid extreme temperatures that can exacerbate itching. Keep the room temperature comfortable and use a humidifier in dry environments.
Stress Management:
Excessive stress can aggravate or start prurigo nodularis symptoms. Include stress-reduction strategies in your everyday practise, such as yoga, meditation, mindfulness, and relaxation exercises.
Itch-Relief Measures:
Keep cool packs in the refrigerator and apply them to itchy areas to provide temporary relief.
Trim fingernails to prevent skin damage from scratching.
Use over-the-counter or prescription anti-itch creams as recommended by a dermatologist.
Medications:
In extreme situations, your doctor might recommend oral or topical drugs to reduce inflammation and itching.
Dietary Considerations:
Some people report symptom improvement by avoiding certain trigger foods or following an anti-inflammatory diet. It may be worth exploring dietary modifications with the guidance of a healthcare professional.
Supportive Clothing:
Special clothing designed to reduce friction and pressure on affected areas can provide relief and prevent further skin damage.
Psychological Support:
PN can take a toll on mental health. Consider seeking support from a therapist or support group to help cope with the emotional aspects of living with this condition.
Regular Follow-ups:
Continuously consult with a dermatologist to monitor the condition, adjust treatment plans, and explore new therapies as they become available.
triamcinolone acetonide
Concentrations of triamcinolone acetonide as low as 2.5 mg/mL have demonstrated effectiveness, but for pruriginous lesions that are more extensively scarred, higher concentrations may be necessary.
triamcinolone acetonide at concentrations ranging from 10 mg/mL-20 mg/mL into the affected area has demonstrated the ability to reduce the elevation of lesions and alleviate itching.
pimecrolimus 1%
pimecrolimus 1% demonstrates comparable efficacy to hydrocortisone and can be incorporated into a prolonged treatment plan.
menthol
In concentrations below 5%, menthol can help reduce itching by increasing the threshold for stimuli that trigger itching.
thalidomide is an immunomodulatory drug that functions as a central and peripheral depressant and has anti-inflammatory qualities due to its inhibition of tumour necrosis factor-α.
It has been applied to dermatological conditions that don’t respond to conventional treatment. It is believed that prurigo nodularis neurotoxic effects are that provide it with its therapeutic activity. 42 patients were treated with an average of 100 mg of thalidomide for 105 weeks in the largest study to date on the use of thalidomide in refractory prurigo nodularis.
Compared to thalidomide, lenalidomide has a 2000-fold higher potency.
Patients who have prurigo nodularis and are resistant to thalidomide and other treatments may benefit from lenalidomide as a stand-alone treatment.
lenalidomide has the advantage of reducing the frequency of peripheral neuropathy. It can also reduce the risk of thromboembolic events when taken with aspirin.
Antihistamines play a crucial role in the treatment of prurigo nodularis by targeting the elevated mast cell count within prurigo nodularis lesions.
A case series has demonstrated positive outcomes in individuals with chronic pruritus when employing a high-dose, non-sedating antihistamine during the day and transitioning to a sedating antihistamine at night.
fexofenadine & montelukast
The concurrent treatment with fexofenadine and montelukast demonstrated significant enhancements in skin lesions and alleviated itching in 11 out of 15 individuals suffering from both prurigo nodularis and pemphigoid nodularis. Remarkably, one patient achieved complete remission because of this treatment regimen.
cyclosporine
Patients with severe, refractory prurigo nodularis may benefit from the consideration of oral immunosuppressive treatment.
A retrospective study conducted at a single institution observed notable clinical enhancements, including a reduction in skin lesions and decreased itching, with the use of cyclosporine. On average, these improvements were observed within three weeks, with an average dosage of 3.1 mg/kg. This investigation, which involved eight patients, revealed that six of them achieved complete remission, and there were no recurrences observed after discontinuation of the treatment.
tacrolimus oral
Oral administration of tacrolimus exhibited a remarkable decrease in pruritus for a patient previously managed with cyclosporine to address prurigo nodularis condition.
Cryotherapy: Cryotherapy involves freezing the prurigo nodules using liquid nitrogen. This is a common approach for smaller, localized nodules. Cryotherapy can destroy the affected tissue and provide relief from itching.
Pulsed-dye laser treatment has the potential to decrease the blood vessel prominence in specific skin lesions.
Diagnosis and Assessment:
Proper diagnosis of prurigo nodularis is essential, often involving a clinical examination by a dermatologist or a healthcare provider with expertise in dermatology.
Detailed medical history and examination of skin lesions to confirm the diagnosis.
Assessment of the severity of symptoms, impact on the patient’s daily life, and any underlying medical conditions.
Education and Counseling:
Patient education is crucial to help individuals understand the nature of prurigo Nodularis and the chronicity of the condition.
Counseling regarding the importance of avoiding scratching and the potential for secondary infections.
Discussing treatment options and setting realistic expectations for improvement.
Topical Treatments:
Emollients and moisturizers to keep the skin hydrated and minimize dryness, which can exacerbate itching.
Topical corticosteroids to reduce inflammation and itching.
Topical calcineurin inhibitors (e.g., tacrolimus or pimecrolimus) to reduce inflammation and itching, especially in sensitive areas.
Topical anesthetics or cooling agents to provide temporary relief from itching.
Systemic Medications:
In more severe cases or when topical treatments are ineffective, systemic medications may be prescribed.
Antihistamines to help control itching and improve sleep quality.
Immunosuppressants like cyclosporine or methotrexate to reduce inflammation and itching.
Gabapentin or pregabalin for neuropathic itching in some cases.
If secondary bacterial infections are present, antibiotics may be prescribed.
Behavioral and Psychological Interventions:
Patients can manage the impulse to itch and treat any psychological issues contributing to the illness by using cognitive-behavioral therapy or other counselling procedures.
Stress management techniques, as stress can exacerbate itching.
Habit-reversal training to help patients become more aware of their scratching behavior and develop strategies to reduce it.
Phototherapy:
Narrowband UVB phototherapy can be effective in some cases, particularly for reducing itching and inflammation.
PUVA (psoralen plus UVA) therapy may also be considered in certain situations.
Support and Follow-up:
Regular follow-up appointments to monitor the progress of treatment and adjust the management plan as needed.
Encouragement and support for the patient to adhere to the prescribed treatment regimen.
Addressing any adverse effects or complications associated with the treatments.
Lifestyle Modifications:
Encouraging patients to avoid triggers that worsen itching, such as tight clothing, heat, and certain fabrics.
Promoting a healthy, well-balanced diet and adequate hydration to support skin health.
Research and Emerging Therapies:
Patients may be informed about ongoing research and clinical trials for potential new treatments or therapies.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
